Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Bullboard Posts
Comment by Lynx9on Feb 01, 2020 2:55pm
122 Views
Post# 30629484

RE:RE:Sachs Presentation

RE:RE:Sachs Presentation HenrySC, first I want to thank you for your long informed postings and replies. I'm afreaid that, for me anyway, reading reports on amyloids, neurons, oligomers etc. make my eyes glaze over and I can get to the end of the paper and sit in wonder to what I just read:). Fascinating stuff I must admit and certainly beyond my comprehension so when I read post like yours I'm a little more educated on this matter.
I follow and invest in this company, as others, knowing full well that it is 99% speculation at this point and rather don't understand why or how others see this as a safe bet. So, becoming irritable and down right nasty in comments regarding anyone posting informative information on this subject only shows me the total ignorance that many have on this subject on this board.
I would hope others post their knowledgable views on this subject, whether I understand it or not, so I can gather the different views and assess the possibility of future following of this particular company.
For those of you who thought this may perhaps be a "get rich quick" opportunity, please refrain from blaming the rather well educated individuals in PMN, who, like you, see an opportunity and believe they have a breakthrough of sorts that may or maynot be a success. 
As I mentioned above, I have invested in PMN as a "long shot speculation" the difference however is that I didn't bet the bank!
Bullboard Posts